CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities
Net income (loss)	$ (64,993)	$ (29,581)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss (gain) on debt modification and extinguishment, net	35,220	0
Depreciation and amortization, net	94,606	88,384
Asset impairment:	1,787	1,708
Deferred income tax (benefit) provision	(1,157)	(425)
Operating lease expense adjustment	(3,853)	(13,089)
Change in fair value of derivatives	1,142	(3,087)
Loss (gain) on sale of assets, net	0	(704)
Non-cash stock-based compensation expense	3,979	3,273
Property and casualty insurance income	(1,415)	(2,626)
Changes in operating assets and liabilities:
Accounts receivable, net	(6,002)	(1,253)
Prepaid expenses and other assets, net	(5,104)	1,708
Prepaid insurance premiums financed with notes payable	(22,392)	(23,319)
Trade accounts payable and accrued expenses	(15,148)	(25,109)
Refundable fees and deferred revenue	4,719	2,725
Operating lease assets and liabilities for lessor capital expenditure reimbursements	2,013	249
Net cash provided by (used in) operating activities	23,402	(1,146)
Cash Flows from Investing Activities
Sale and maturities of marketable securities	20,000	30,000
Capital expenditures, net of related payables	(41,817)	(44,399)
Acquisition of assets	(311,028)	0
Proceeds from sale of assets, net	0	849
Property and casualty insurance proceeds	1,415	2,642
Change in lease acquisition deposits, net	5,000	0
Purchase of interest rate cap instruments	(2,170)	(629)
Proceeds from interest rate cap instruments	1,900	4,659
Other	(55)	(68)
Net cash provided by (used in) investing activities	(326,755)	(6,946)
Cash Flows from Financing Activities
Proceeds from debt	320,673	80,923
Repayment of debt and financing lease obligations	(70,338)	(20,502)
Payment of financing costs, net of related payables	(5,909)	(2,934)
Payments of employee taxes for withheld shares	(4,757)	(3,397)
Net cash provided by (used in) financing activities	239,669	54,090
Net increase (decrease) in cash, cash equivalents, and restricted cash	(63,684)	45,998
Cash, cash equivalents, and restricted cash at beginning of period	379,840	349,668
Cash, cash equivalents, and restricted cash at end of period	$ 316,156	$ 395,666